The Dow Chemical Company Diamond

Biopharmaceuticals & Peptides

  • Capabilities and Services
    • Molecular Biology
      • Expression Technologies
      • Pfēnex Expression Technology
    • Fermentation Process Development
    • Purification Process Development
    • Analytical Development
    • Pilot Manufacturing
    • cGMP Manufacturing
    • Project Lifecycle Timeline
    • PEGylation
      • Why PEGs?
      • Chemistry
      • Analytical
      • Why Dowpharma?
      • Dowpharma PEGs
      • Ordering PEGs
        • Order Summary
        • Checkout
        • Thank You
      • Events Calendar
  • Facilities
  • Literature and Resources
  • News Center
    • Dow Announces Price Increases of its Epoxy Novolac Resins In Asia Pacific, Europe, Middle East, Africa, India and Pakistan
    • DowpharmaSM Announces Multi-Product License Agreement with Merck
    • Dowpharma<sup>SM</sup> Signs Fourth Collaboration Agreement In First Quarter of 2006 for <i>Pf</i>ēnex Expression Technology™
    • DOR BioPharma Announces Advances in Mucosal Vaccines for Botulinum Toxin
    • VGX Pharmaceuticals and Dowpharma<sup>SM</sup> Sign Research and Development Agreement for VGX’s Lead Cancer Compound
    • Viventia Biotech and Dowpharma<sup>SM</sup> Announce a Multi-Product Commercial License Agreement using <i>Pf</i>ēnex Expression Technology™ from Dowpharma
    • DOR BioPharma and Dowpharma<sup>SM</sup> Complete Feasibility Study for Production of BT-VACC™, DOR’s Recombinant Botulinum Vaccine
    • DOR BioPharma and Dowpharma Enter into a Joint Development Agreement for BT-VACC, DOR’s Oral Botulinum Toxin Vaccine
    • Dowpharma<sup>SM</sup> Announces Commercial License Agreement for <i>Pf</i><script>document.write(unescape('%u0113'));</script>nex Expression Technology™ with Iomai Corporation
    • <i>Smithsonian National Museum of American History</i> - Dow Donates DNA Fermenter to National Museum of American History
    • Cambrex Named First Biopharmaceutical Manufacturing Partner for <i>Pf</i>ēnex Expression Technology™ from Dowpharma<sup>SM</sup>
    • Dowpharma Relaunches Web Site, Will Make Donation to UNICEF
    • Dowpharma<sup>SM</sup> Announces Agreement with Pfizer Inc using <i>Pf</i><script>document.write(unescape('%u0113'));</script>nex Expression Technology<sup>TM</sup> and Dow Solvent Extraction Tech.
    • Dowpharma Sharpens Focus on New Expression Systems; Smithfield Facility Will be Closed
    • Dowpharma Consolidates Biopharmaceutical Process Development to San Diego
    • Dowpharma Announces Biologics Peptide Manufacture
    • Dow Expands Presence in Pharmaceutical Market, Uniting Existing Offers Under Dowpharma Portfolio
    • Dowpharma Introduces Next Generation Microbial Expression System for Production of Biotherapeutics
  • Events Calendar
  • Contact Us
  • PEGylation

Literature and Resources

pdf icon Introduction to Dowpharma (154 KB PDF)
pdf icon Brochure: Biopharmaceutical Development (197 KB PDF)
pdf icon Brochure: Emerging Pharma: The Road to Drug Commercialization (259 KB PDF)
pdf icon Brochure: Build a Better PEGylation Team (182 KB PDF)
pdf icon Tech Brief: Dowpharma's Biological Approaches to Peptide Production (447 KB PDF)
Pfēnex Expression Technology™
pdf icon Article: Pseudomonas fluorescens – A robust manufacturing platform (71 KB PDF)
pdf icon Article: Heterologous Protein Production in P. fluorescens (594 KB PDF)
pdf icon Pseudomonas fluorescens FAQ (136 KB PDF)
pdf icon Pseudomonas fluorescens – Regulatory (131 KB PDF)
pdf icon Tech Brief: Pseudomonas fluorescens – a robust and high yield platform for protein / biopharmaceutical manufacturing (723 KB PDF)
pdf icon Tech Brief: Use of pyrF to Stack Multiple Deletions in Pseudomonas fluorescens and to Stabilize Protein Production Plasmids without Antibiotic Resistance Markers (368 KB PDF)
pdf icon Pfēnex Expression Technology for High Throughput Applications (224 KB PDF)
pdf icon Pfēnex Expression Technology - The Best Expressions (835 KB PDF)
pdf icon Pfēnex Expression Technology for Antibody Derivatives (260 KB PDF)

Get Adobe Reader In order to view some information you may need to download Adobe Reader.


®™* Trademark of The Dow Chemical Company ("Dow") or an affiliated company of Dow

 
Biopharmaceuticals, Peptides & PEGylation

Dow Home  Privacy Statement  Internet Disclaimer  Accessibility Statement  Site Map

Copyright © The Dow Chemical Company (1995-2008). All Rights Reserved.